James Joseph Faremouth Jr, DO | |
8360 Sierra Meadows Blvd, Naples, FL 34113-7328 | |
(239) 624-8300 | |
(239) 430-7805 |
Full Name | James Joseph Faremouth Jr |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 28 Years |
Location | 8360 Sierra Meadows Blvd, Naples, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124056015 | NPI | - | NPPES |
09467 | Other | FL | FL BC |
AH972X | Other | FL | MEDICARE |
280274100 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS9581 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Avow Hospice Inc | Naples, FL | Hospice |
Premier Place At The Glenview | Naples, FL | Nursing home |
Promedica Skilled Nursing And Rehabilitation (lely | Naples, FL | Nursing home |
Entity Name | Dr Js House Calls Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215333596 PECOS PAC ID: 1052673498 Enrollment ID: O20180322000903 |
News Archive
After a transplant - and to assure that the new organ is not rejected - patients are put on life-long therapy to suppress their immune system, which, nevertheless, needs to be left intact enough to be able to defend the body against all kinds of disease. A tricky balance as the many rejected organs attest. But a discovery by Maria Monteiro and Luis Graça, two Portuguese scientists, could change all this, at least for the liver.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.
Roche and Arizona Technology Enterprises (AzTE) announced today an agreement to license several technologies developed by Dr. Stuart Lindsay at the Biodesign Institute- at Arizona State University and Dr. Colin Nuckolls of the Columbia University Nanoscience Center for the development of a revolutionary DNA sequencing system.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
James Joseph Faremouth Jr, DO 8360 Sierra Meadows Blvd, Naples, FL 34113-7328 Ph: (239) 624-8300 | James Joseph Faremouth Jr, DO 8360 Sierra Meadows Blvd, Naples, FL 34113-7328 Ph: (239) 624-8300 |
News Archive
After a transplant - and to assure that the new organ is not rejected - patients are put on life-long therapy to suppress their immune system, which, nevertheless, needs to be left intact enough to be able to defend the body against all kinds of disease. A tricky balance as the many rejected organs attest. But a discovery by Maria Monteiro and Luis Graça, two Portuguese scientists, could change all this, at least for the liver.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.
Roche and Arizona Technology Enterprises (AzTE) announced today an agreement to license several technologies developed by Dr. Stuart Lindsay at the Biodesign Institute- at Arizona State University and Dr. Colin Nuckolls of the Columbia University Nanoscience Center for the development of a revolutionary DNA sequencing system.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 3 days ago
Dr. Emily Christine Essert, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11181 Health Park Blvd, Naples, FL 34110 Phone: 239-624-8130 Fax: 239-624-8131 | |
Dr. William H Ruby, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 3339 E Tamiami Trl Ste 145, Naples, FL 34112 Phone: 239-252-8200 Fax: 239-252-8808 | |
Dr. Jacqueline N Romero, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11181 Health Park Blvd, Suite 2260, Naples, FL 34110 Phone: 239-514-7315 Fax: 239-514-7304 | |
Dr. Kenneth Allen Writesel, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Tamiami Trl N Ste 162, Naples, FL 34102 Phone: 239-316-3323 | |
Rylan Mcquade, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1265 Creekside Pkwy Ste 206, Naples, FL 34108 Phone: 239-658-3000 | |
Hope Michele Chema, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1284 Creekside St, #101, Naples, FL 34108 Phone: 239-658-3710 Fax: 239-591-2154 | |
Dr. Claude J Kenol, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3715 Tamiami Trl E, Naples, FL 34112 Phone: 239-793-6434 Fax: 239-793-2184 |